Article Details
Retrieved on: 2025-04-22 16:42:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The FDA granted regenerative medicine advanced therapy designation to iltamciocel for patients with oropharyngeal dysphagia following head and neck ...
Article found on: www.targetedonc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here